Oculis Holding AG (OCS)
NASDAQ: OCS · Real-Time Price · USD
29.41
-0.58 (-1.93%)
At close: Feb 27, 2026, 4:00 PM EST
29.35
-0.06 (-0.20%)
After-hours: Feb 27, 2026, 7:08 PM EST
Oculis Holding AG Employees
Oculis Holding AG had 49 employees as of December 31, 2024. The number of employees increased by 13 or 36.11% compared to the previous year.
Employees
49
Change (1Y)
13
Growth (1Y)
36.11%
Revenue / Employee
$20,245
Profits / Employee
-$2,664,287
Market Cap
1.70B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49 | 13 | 36.11% |
| Dec 31, 2023 | 36 | 8 | 28.57% |
| Dec 31, 2022 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Agios Pharmaceuticals | 540 |
| Harmony Biosciences Holdings | 268 |
| Tango Therapeutics | 155 |
| Kodiak Sciences | 123 |
| Pharvaris | 118 |
| Definium Therapeutics | 74 |
| Enliven Therapeutics | 65 |
| RAPT Therapeutics | 60 |
OCS News
- 1 day ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewsWire
- 10 days ago - Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - GlobeNewsWire
- 11 days ago - Oculis Appoints Katie Kazem as Chief Legal Officer - GlobeNewsWire
- 6 weeks ago - Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Oculis to Showcase Transformative Late-stage Pipeline in Neuro-ophthalmology and Ophthalmology at the 2026 J.P. Morgan Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Oculis Announces U.S. FDA Breakthrough Therapy Designation Granted to Privosegtor for Treatment of Optic Neuritis - GlobeNewsWire
- 3 months ago - Oculis Reports Q3 2025 Financial Results and Provides Company Update - GlobeNewsWire
- 4 months ago - Oculis to Participate in Upcoming November Investor Conferences - GlobeNewsWire